Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?

NCT01837745 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

776

Enrollment

OTHER

Sponsor class

Conditions

Low Risk Differentiated Thyroid Cancer

Interventions

DRUG: rhTSH stimulation
DRUG: I131
OTHER: Follow up

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris